Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2012

Open Access 01-12-2012 | Original investigation

Plasma NT-proBNP and white matter hyperintensities in type 2 diabetic patients

Authors: Henrik Reinhard, Ellen Garde, Arnold Skimminge, Per Åkeson, Thomas Zoëga Ramsøy, Kaj Winther, Hans-Henrik Parving, Peter Rossing, Peter K Jacobsen

Published in: Cardiovascular Diabetology | Issue 1/2012

Login to get access

Abstract

Elevated plasma N-terminal (NT)-proBNP from the heart as well as white matter hyperintensities (WMH) in the brain predict cardiovascular (CV) mortality in the general population. The cause of poor prognosis associated with elevated P-NT-proBNP is not known but WMH precede strokes in high risk populations. We assessed the association between P-NT-proBNP and WMH or brain atrophy measured with magnetic resonance imaging (MRI) in type 2 diabetic patients, and age-matched controls.

Methods and results

We measured P-NT-proBNP(ng/l) in 20 diabetic patients without prior stroke but with(n = 10) or without(n = 10) asymptomatic coronary artery disease(CAD) in order to include patients with a wide-ranging CV risk profile. All patients and 26 controls had a 3D MRI and brain volumes(ml) with WMH and brain parenchymal fraction(BPF), an indicator of brain atrophy, were determined.
P-NT-proBNP was associated with WMH in linear regression analysis adjusted for CV risk factors(r = 0.94, p = 0.001) and with BPF in univariate analysis(r = 0.57, p = 0.009). Patients divided into groups of increased P-NT-proBNP levels were paralleled with increased WMH volumes(geometric mean[SD];(2.86[5.11] ml and 0.76[2.49] ml compared to patients with low P-NT-proBNP 0.20[2.28] ml, p = 0.003)) and also when adjusted for age, sex and presence of CAD(p = 0.017). The association was strengthened by CV risk factors and we did not find a common heart or brain specific driver of both P-NT-proBNP and WMH. Patients and particular patients with CAD had higher WMH, however no longer after adjustment for age and sex.

Conclusion

P-NT-proBNP was associated with WMH in type 2 diabetic patients, suggesting a linkage between heart and brain disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gerstein HC, Mann JF, Yi Q, et al: Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001, 286 (4): 421-426. 10.1001/jama.286.4.421.CrossRefPubMed Gerstein HC, Mann JF, Yi Q, et al: Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001, 286 (4): 421-426. 10.1001/jama.286.4.421.CrossRefPubMed
2.
go back to reference Gaede P, Lund-Andersen H, Parving H-H, et al: Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008, 358 (6): 580-591. 10.1056/NEJMoa0706245.CrossRefPubMed Gaede P, Lund-Andersen H, Parving H-H, et al: Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008, 358 (6): 580-591. 10.1056/NEJMoa0706245.CrossRefPubMed
3.
go back to reference Wang TJ, Larson MG, Levy D, et al: Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004, 350 (7): 655-663. 10.1056/NEJMoa031994.CrossRefPubMed Wang TJ, Larson MG, Levy D, et al: Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004, 350 (7): 655-663. 10.1056/NEJMoa031994.CrossRefPubMed
4.
go back to reference Debette S, Markus HS: The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. Br Med J. 2010, 341: c3666-10.1136/bmj.c3666.CrossRef Debette S, Markus HS: The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. Br Med J. 2010, 341: c3666-10.1136/bmj.c3666.CrossRef
5.
go back to reference Tarnow L, Gall M-A, Hansen BV, et al: Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes. Diabetologia. 2006, 49: 2256-2262. 10.1007/s00125-006-0359-4.CrossRefPubMed Tarnow L, Gall M-A, Hansen BV, et al: Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes. Diabetologia. 2006, 49: 2256-2262. 10.1007/s00125-006-0359-4.CrossRefPubMed
6.
go back to reference Whiteley W, Wardlaw J, Dennis M, et al: Blood biomarkers for the diagnosis of acute cerebrovascular diseases: a prospective cohort study. Cerebrovasc Dis. 2011, 32 (2): 141-147. 10.1159/000328517.CrossRefPubMed Whiteley W, Wardlaw J, Dennis M, et al: Blood biomarkers for the diagnosis of acute cerebrovascular diseases: a prospective cohort study. Cerebrovasc Dis. 2011, 32 (2): 141-147. 10.1159/000328517.CrossRefPubMed
7.
go back to reference Shibazaki K, Kimura K, Iguchi Y, et al: Plasma brain natriuretic peptide can be a biological marker to distinguish cardioembolic stroke from other stroke types in acute ischemic stroke. Intern Med. 2009, 48 (5): 259-264. 10.2169/internalmedicine.48.1475.CrossRefPubMed Shibazaki K, Kimura K, Iguchi Y, et al: Plasma brain natriuretic peptide can be a biological marker to distinguish cardioembolic stroke from other stroke types in acute ischemic stroke. Intern Med. 2009, 48 (5): 259-264. 10.2169/internalmedicine.48.1475.CrossRefPubMed
8.
go back to reference Pantoni L, Garcia JH: Pathogenesis of leukoaraiosis: a review. Stroke. 1997, 28 (3): 652-659. 10.1161/01.STR.28.3.652.CrossRefPubMed Pantoni L, Garcia JH: Pathogenesis of leukoaraiosis: a review. Stroke. 1997, 28 (3): 652-659. 10.1161/01.STR.28.3.652.CrossRefPubMed
9.
go back to reference Hachinski V: World Stroke Day 2008: "little strokes, big trouble". Stroke. 2008, 39 (9): 2407-2420. 10.1161/STROKEAHA.108.531681.CrossRefPubMed Hachinski V: World Stroke Day 2008: "little strokes, big trouble". Stroke. 2008, 39 (9): 2407-2420. 10.1161/STROKEAHA.108.531681.CrossRefPubMed
10.
go back to reference Leary MC, Saver JL: Annual incidence of first silent stroke in the United States: a preliminary estimate. Cerebrovasc Dis. 2003, 16 (3): 280-285. 10.1159/000071128.CrossRefPubMed Leary MC, Saver JL: Annual incidence of first silent stroke in the United States: a preliminary estimate. Cerebrovasc Dis. 2003, 16 (3): 280-285. 10.1159/000071128.CrossRefPubMed
11.
go back to reference Reinhard H, Hansen PR, Persson F, et al: Elevated NT-proBNP and coronary calcium score in relation to coronary artery disease in asymptomatic type 2 diabetic patients with elevated urinary albumin excretion rate. Nephrol Dial Transplant. 2011, 26 (10): 3242-3249. 10.1093/ndt/gfr009.CrossRefPubMed Reinhard H, Hansen PR, Persson F, et al: Elevated NT-proBNP and coronary calcium score in relation to coronary artery disease in asymptomatic type 2 diabetic patients with elevated urinary albumin excretion rate. Nephrol Dial Transplant. 2011, 26 (10): 3242-3249. 10.1093/ndt/gfr009.CrossRefPubMed
12.
go back to reference Reinhard H, Wiinberg N, Hansen PR, et al: NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperaemia index but not NT-proBNP is an independent predictor of coronary atherosclerosis. Cardiovasc Diabetol. 2011, 10: 71-10.1186/1475-2840-10-71.PubMedCentralCrossRefPubMed Reinhard H, Wiinberg N, Hansen PR, et al: NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperaemia index but not NT-proBNP is an independent predictor of coronary atherosclerosis. Cardiovasc Diabetol. 2011, 10: 71-10.1186/1475-2840-10-71.PubMedCentralCrossRefPubMed
13.
go back to reference Reinhard H, Hansen PR, Wiinberg N, et al: NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients. Cardiovasc Diabetol. 2012, 11: 19-10.1186/1475-2840-11-19.PubMedCentralCrossRefPubMed Reinhard H, Hansen PR, Wiinberg N, et al: NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients. Cardiovasc Diabetol. 2012, 11: 19-10.1186/1475-2840-11-19.PubMedCentralCrossRefPubMed
14.
go back to reference Tombaugh TN, McIntyre NJ: The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992, 40 (9): 922-935.CrossRefPubMed Tombaugh TN, McIntyre NJ: The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992, 40 (9): 922-935.CrossRefPubMed
15.
go back to reference Smith SM, Zhang Y, Jenkinson M, et al: Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage. 2002, 17 (1): 479-489. 10.1006/nimg.2002.1040.CrossRefPubMed Smith SM, Zhang Y, Jenkinson M, et al: Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage. 2002, 17 (1): 479-489. 10.1006/nimg.2002.1040.CrossRefPubMed
16.
go back to reference Pikula A, Beiser AS, DeCarli C, et al: Multiple biomarkers and risk of clinical and subclinical vascular brain injury: the Framingham Offspring Study. Circulation. 2012, 125 (17): 2100-2107. 10.1161/CIRCULATIONAHA.110.989145.PubMedCentralCrossRefPubMed Pikula A, Beiser AS, DeCarli C, et al: Multiple biomarkers and risk of clinical and subclinical vascular brain injury: the Framingham Offspring Study. Circulation. 2012, 125 (17): 2100-2107. 10.1161/CIRCULATIONAHA.110.989145.PubMedCentralCrossRefPubMed
17.
go back to reference Debette S, Beiser A, DeCarli C, et al: Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke. 2010, 41 (4): 600-606. 10.1161/STROKEAHA.109.570044.PubMedCentralCrossRefPubMed Debette S, Beiser A, DeCarli C, et al: Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke. 2010, 41 (4): 600-606. 10.1161/STROKEAHA.109.570044.PubMedCentralCrossRefPubMed
18.
go back to reference Wada A, Tsutamoto T, Matsuda Y, et al: Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors. Circulation. 1994, 89 (5): 2232-2240. 10.1161/01.CIR.89.5.2232.CrossRefPubMed Wada A, Tsutamoto T, Matsuda Y, et al: Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors. Circulation. 1994, 89 (5): 2232-2240. 10.1161/01.CIR.89.5.2232.CrossRefPubMed
19.
go back to reference Schultz HD, Gardner DG, Deschepper CF, et al: Vagal C-fiber blockade abolishes sympathetic inhibition by atrial natriuretic factor. Am J Physiol. 1988, 255 (1 Pt 2): R6-R13.PubMed Schultz HD, Gardner DG, Deschepper CF, et al: Vagal C-fiber blockade abolishes sympathetic inhibition by atrial natriuretic factor. Am J Physiol. 1988, 255 (1 Pt 2): R6-R13.PubMed
20.
go back to reference Takahashi K, Totsune K, Sone M, et al: Human brain natriuretic peptide-like immunoreactivity in human brain. Peptides. 1992, 13 (1): 121-123. 10.1016/0196-9781(92)90149-W.CrossRefPubMed Takahashi K, Totsune K, Sone M, et al: Human brain natriuretic peptide-like immunoreactivity in human brain. Peptides. 1992, 13 (1): 121-123. 10.1016/0196-9781(92)90149-W.CrossRefPubMed
21.
go back to reference Brosnan MJ, Clark JS, Jeffs B, et al: Genes encoding atrial and brain natriuretic peptides as candidates for sensitivity to brain ischemia in stroke-prone hypertensive rats. Hypertension. 1999, 33 (1 Pt 2): 290-297.CrossRefPubMed Brosnan MJ, Clark JS, Jeffs B, et al: Genes encoding atrial and brain natriuretic peptides as candidates for sensitivity to brain ischemia in stroke-prone hypertensive rats. Hypertension. 1999, 33 (1 Pt 2): 290-297.CrossRefPubMed
22.
go back to reference Jiang C, Lu H, Vincent KA, et al: Gene expression profiles in human cardiac cells subjected to hypoxia or expressing a hybrid form of HIF-1 alpha. Physiol Genomics. 2002, 8 (1): 23-32.CrossRefPubMed Jiang C, Lu H, Vincent KA, et al: Gene expression profiles in human cardiac cells subjected to hypoxia or expressing a hybrid form of HIF-1 alpha. Physiol Genomics. 2002, 8 (1): 23-32.CrossRefPubMed
23.
go back to reference Nakagawa K, Yamaguchi T, Seida M, et al: Plasma concentrations of brain natriuretic peptide in patients with acute ischemic stroke. Cerebrovasc Dis. 2005, 19 (3): 157-164. 10.1159/000083249.CrossRefPubMed Nakagawa K, Yamaguchi T, Seida M, et al: Plasma concentrations of brain natriuretic peptide in patients with acute ischemic stroke. Cerebrovasc Dis. 2005, 19 (3): 157-164. 10.1159/000083249.CrossRefPubMed
24.
go back to reference Sharma JC, Ananda K, Ross I, et al: N-terminal proBrain natriuretic peptide levels predict short-term poststroke survival. J Stroke Cerebrovasc Dis. 2006, 15 (3): 121-127. 10.1016/j.jstrokecerebrovasdis.2006.03.003.CrossRefPubMed Sharma JC, Ananda K, Ross I, et al: N-terminal proBrain natriuretic peptide levels predict short-term poststroke survival. J Stroke Cerebrovasc Dis. 2006, 15 (3): 121-127. 10.1016/j.jstrokecerebrovasdis.2006.03.003.CrossRefPubMed
25.
go back to reference Iltumur K, Yavavli A, Apak I, et al: Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke. Am Heart J. 2006, 151 (5): 1115-1122. 10.1016/j.ahj.2005.05.022.CrossRefPubMed Iltumur K, Yavavli A, Apak I, et al: Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke. Am Heart J. 2006, 151 (5): 1115-1122. 10.1016/j.ahj.2005.05.022.CrossRefPubMed
26.
go back to reference Modrego PJ, Boned B, Berlanga JJ, et al: Plasmatic B-type natriuretic peptide and C-reactive protein in hyperacute stroke as markers of CT-evidence of brain edema. Int J Med Sci. 2008, 5 (1): 18-23.PubMedCentralCrossRefPubMed Modrego PJ, Boned B, Berlanga JJ, et al: Plasmatic B-type natriuretic peptide and C-reactive protein in hyperacute stroke as markers of CT-evidence of brain edema. Int J Med Sci. 2008, 5 (1): 18-23.PubMedCentralCrossRefPubMed
27.
go back to reference Peng XL, Lin ZP, Zhang RK, et al: [B-type natriuretic peptides and subclinical target organ damage in essential hypertensive patients]. Nan Fang Yi Ke Da Xue Xue Bao. 2010, 30 (10): 2347-2350.PubMed Peng XL, Lin ZP, Zhang RK, et al: [B-type natriuretic peptides and subclinical target organ damage in essential hypertensive patients]. Nan Fang Yi Ke Da Xue Xue Bao. 2010, 30 (10): 2347-2350.PubMed
28.
go back to reference Abdullah SM, Khera A, Das SR, et al: Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of n-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas Heart Study). Am J Cardiol. 2005, 96 (9): 1284-1289. 10.1016/j.amjcard.2005.06.073.CrossRefPubMed Abdullah SM, Khera A, Das SR, et al: Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of n-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas Heart Study). Am J Cardiol. 2005, 96 (9): 1284-1289. 10.1016/j.amjcard.2005.06.073.CrossRefPubMed
29.
go back to reference Wiersma JJ, van der Zee PM, van Straalen JP, Fischer JC, van Eck-Smit BL, Tijssen JG, Trip MD, Piek JJ, Verberne HJ: NT-pro-BNP is associated with inducible myocardial ischemia in mildly symptomatic type 2 diabetic patients. Int J Cardiol. 2010, 145 (2): 295-6. 10.1016/j.ijcard.2009.10.035. November 19CrossRefPubMed Wiersma JJ, van der Zee PM, van Straalen JP, Fischer JC, van Eck-Smit BL, Tijssen JG, Trip MD, Piek JJ, Verberne HJ: NT-pro-BNP is associated with inducible myocardial ischemia in mildly symptomatic type 2 diabetic patients. Int J Cardiol. 2010, 145 (2): 295-6. 10.1016/j.ijcard.2009.10.035. November 19CrossRefPubMed
30.
go back to reference Sakai H, Tsutamoto T, Ishikawa C, et al: Direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP secretion and extent of coronary artery stenosis in patients with stable coronary artery disease. Circ J. 2007, 71 (4): 499-505. 10.1253/circj.71.499.CrossRefPubMed Sakai H, Tsutamoto T, Ishikawa C, et al: Direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP secretion and extent of coronary artery stenosis in patients with stable coronary artery disease. Circ J. 2007, 71 (4): 499-505. 10.1253/circj.71.499.CrossRefPubMed
31.
go back to reference Magnusson M, Jovinge S, Shahgaldi K, et al: Brain natriuretic peptide is related to diastolic dysfunction whereas urinary albumin excretion rate is related to left ventricular mass in asymptomatic type 2 diabetes patients. Cardiovasc Diabetol. 2010, 9: 2-10.1186/1475-2840-9-2.PubMedCentralCrossRefPubMed Magnusson M, Jovinge S, Shahgaldi K, et al: Brain natriuretic peptide is related to diastolic dysfunction whereas urinary albumin excretion rate is related to left ventricular mass in asymptomatic type 2 diabetes patients. Cardiovasc Diabetol. 2010, 9: 2-10.1186/1475-2840-9-2.PubMedCentralCrossRefPubMed
32.
go back to reference Christensen LL, Anker-Nielsen A, Almdal TP: Development in Quality of Treatment in Complicated Type 2 Diabetes Assessed by the Proportion of Patients Reaching ADA Goals. Diab. 2010, 59: A180-A181. Christensen LL, Anker-Nielsen A, Almdal TP: Development in Quality of Treatment in Complicated Type 2 Diabetes Assessed by the Proportion of Patients Reaching ADA Goals. Diab. 2010, 59: A180-A181.
33.
go back to reference Gaede P, Hildebrandt P, Hess G, et al: Plasma N-terminal pro-brain natriuretic peptide as a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria. Diabetologia. 2005, 48 (1): 156-163. 10.1007/s00125-004-1607-0.CrossRefPubMed Gaede P, Hildebrandt P, Hess G, et al: Plasma N-terminal pro-brain natriuretic peptide as a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria. Diabetologia. 2005, 48 (1): 156-163. 10.1007/s00125-004-1607-0.CrossRefPubMed
34.
go back to reference Nakatsuji H, Kishida K, Funahashi T, et al: Hyperinsulinemia correlates with low levels of plasma B-type natriuretic peptide in Japanese men irrespective of fat distribution. Cardiovasc Diabetol. 2012, 11: 22-10.1186/1475-2840-11-22.PubMedCentralCrossRefPubMed Nakatsuji H, Kishida K, Funahashi T, et al: Hyperinsulinemia correlates with low levels of plasma B-type natriuretic peptide in Japanese men irrespective of fat distribution. Cardiovasc Diabetol. 2012, 11: 22-10.1186/1475-2840-11-22.PubMedCentralCrossRefPubMed
35.
go back to reference Magnusson M, Melander O, Israelsson B, et al: Elevated plasma levels of Nt-proBNP in patients with type 2 diabetes without overt cardiovascular disease. Diabetes Care. 2004, 27 (8): 1929-1935. 10.2337/diacare.27.8.1929.CrossRefPubMed Magnusson M, Melander O, Israelsson B, et al: Elevated plasma levels of Nt-proBNP in patients with type 2 diabetes without overt cardiovascular disease. Diabetes Care. 2004, 27 (8): 1929-1935. 10.2337/diacare.27.8.1929.CrossRefPubMed
36.
go back to reference Cakir Z, Saritas A, Emet M, et al: A prospective study of brain natriuretic peptide levels in three subgroups: Stroke with hypertension, stroke without hypertension, and hypertension alone. Ann Indian Acad Neurol. 2010, 13 (1): 47-51. 10.4103/0972-2327.61277.PubMedCentralCrossRefPubMed Cakir Z, Saritas A, Emet M, et al: A prospective study of brain natriuretic peptide levels in three subgroups: Stroke with hypertension, stroke without hypertension, and hypertension alone. Ann Indian Acad Neurol. 2010, 13 (1): 47-51. 10.4103/0972-2327.61277.PubMedCentralCrossRefPubMed
37.
go back to reference Saritas A, Cakir Z, Emet M, et al: Factors affecting the B-type natriuretic peptide levels in stroke patients. Ann Acad Med Singapore. 2010, 39 (5): 385-389.PubMed Saritas A, Cakir Z, Emet M, et al: Factors affecting the B-type natriuretic peptide levels in stroke patients. Ann Acad Med Singapore. 2010, 39 (5): 385-389.PubMed
38.
go back to reference Fukuda H, Kitani M: Differences between treated and untreated hypertensive subjects in the extent of periventricular hyperintensities observed on brain MRI. Stroke. 1995, 26 (9): 1593-1597. 10.1161/01.STR.26.9.1593.CrossRefPubMed Fukuda H, Kitani M: Differences between treated and untreated hypertensive subjects in the extent of periventricular hyperintensities observed on brain MRI. Stroke. 1995, 26 (9): 1593-1597. 10.1161/01.STR.26.9.1593.CrossRefPubMed
39.
go back to reference Mantyla R, Erkinjuntti T, Salonen O, et al: Variable agreement between visual rating scales for white matter hyperintensities on MRI. Comparison of 13 rating scales in a poststroke cohort. Stroke. 1997, 28 (8): 1614-1623. 10.1161/01.STR.28.8.1614.CrossRefPubMed Mantyla R, Erkinjuntti T, Salonen O, et al: Variable agreement between visual rating scales for white matter hyperintensities on MRI. Comparison of 13 rating scales in a poststroke cohort. Stroke. 1997, 28 (8): 1614-1623. 10.1161/01.STR.28.8.1614.CrossRefPubMed
40.
go back to reference van HB, de Leeuw FE, Weinstein HC, et al: Brain imaging in patients with diabetes: a systematic review. Diabetes Care. 2006, 29 (11): 2539-2548. 10.2337/dc06-1637.CrossRef van HB, de Leeuw FE, Weinstein HC, et al: Brain imaging in patients with diabetes: a systematic review. Diabetes Care. 2006, 29 (11): 2539-2548. 10.2337/dc06-1637.CrossRef
41.
go back to reference Jongen C, van der Grond J, Kappelle LJ, et al: Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus. Diabetologia. 2007, 50 (7): 1509-1516. 10.1007/s00125-007-0688-y.PubMedCentralCrossRefPubMed Jongen C, van der Grond J, Kappelle LJ, et al: Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus. Diabetologia. 2007, 50 (7): 1509-1516. 10.1007/s00125-007-0688-y.PubMedCentralCrossRefPubMed
42.
go back to reference De BJ, Tiehuis AM, van den Berg E, et al: Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes. Diabetes Care. 2010, 33 (6): 1309-1314. 10.2337/dc09-1923.CrossRef De BJ, Tiehuis AM, van den Berg E, et al: Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes. Diabetes Care. 2010, 33 (6): 1309-1314. 10.2337/dc09-1923.CrossRef
Metadata
Title
Plasma NT-proBNP and white matter hyperintensities in type 2 diabetic patients
Authors
Henrik Reinhard
Ellen Garde
Arnold Skimminge
Per Åkeson
Thomas Zoëga Ramsøy
Kaj Winther
Hans-Henrik Parving
Peter Rossing
Peter K Jacobsen
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2012
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-11-119

Other articles of this Issue 1/2012

Cardiovascular Diabetology 1/2012 Go to the issue